56 results
Page 2 of 3
8-K
EX-99.1
0qrfkc
30 Mar 20
PhaseBio Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Recent Business Highlights
8:08am
S-3
6mb3ih30mllpud8q
27 Dec 19
Shelf registration
5:28pm
S-3
EX-4.2
gibfh43
27 Dec 19
Shelf registration
5:28pm
8-K
EX-99.1
ukn9 mjs1d
14 Nov 19
PhaseBio Reports Third Quarter 2019 Financial Results and Recent Corporate Progress
8:16am
8-K
EX-99.1
lg1frxk
13 Aug 19
PhaseBio Reports Second Quarter 2019 Financial Results and Recent Corporate Progress
4:05pm
8-K
EX-99.1
klr19c3sndnct7
9 May 19
PhaseBio Reports First Quarter 2019 Financial and Business Results
4:05pm
424B4
m8k phsvwvbgox9m7b
12 Apr 19
Prospectus supplement with pricing info
4:32pm
8-K
EX-10.1
6fvw683xfuy6u3g2
9 Apr 19
PhaseBio Announces Global License of PB1023 for the Treatment of Sarcopenia-Related Diseases to ImmunoForge
8:01am
DRS
g3z3je3868h4z
29 Mar 19
Draft registration statement
12:00am
10-K
EX-10.13
xh0ln8
26 Mar 19
Annual report
4:45pm
10-K
8ekf5 8gh
26 Mar 19
Annual report
4:45pm
10-K
EX-10.14
v3cq8xqoqggbl1nsm
26 Mar 19
Annual report
4:45pm